UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

November 19, 2015

Date of Report (Date of earliest event reported)

 

 

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-15317   98-0152841

(State or Other Jurisdiction

of Incorporation)

   (Commission
File Number)		  

(I.R.S. Employer

Identification No.)

9001 Spectrum Center Boulevard

San Diego, California 92123

(Address of Principal Executive Offices) (Zip Code)

(858) 836-5000

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On November 19, 2015, US Pacific time, at our annual meeting of stockholders, our stockholders (1) elected the three nominees listed below to serve on our board of directors; (2) ratified the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2016; and (3) approved the compensation of our named executive officers.

 

     For      Against      Abstain      Broker
Non-Votes		  
Item of Business No. 1: Elect the following three nominees to serve for three-year terms until our annual meeting of stockholders in 2018:            

Peter Farrell

      91,888,635         6,653,132         368,542         7,439,910   

Gary Pace

      81,948,101         14,597,001         2,365,207         7,439,910   

Ron Taylor

      87,497,603         9,048,196         2,364,510         7,439,910   
     For      Against      Abstain      Broker
Non-Votes		  
Item No. 2: Ratify KPMG LLP as independent registered public accounting firm.      105,608,678         423,862         317,679      
     For      Against      Abstain      Broker
Non-Votes		  
Item No. 3: Approve, on an advisory basis, the compensation of ResMed’s named executive officers.      83,643,119         12,130,927         3,136,263         7,439,910   

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

    RESMED INC.
Date: November 24, 2015     By:  

/s/ David Pendarvis

     

David Pendarvis

Chief administrative officer, global general counsel and secretary

ResMed (NYSE:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ResMed Charts.
ResMed (NYSE:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ResMed Charts.